Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erlichman

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
The Hsp90 chaperone complex as a novel target for cancer therapyM P Goetz, D O Toft, M M Ames, et al.
Biochemical Pharmacology|June 29, 1995
Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicityJ Pressacco, B Mitrovski, D W Hedley, et al.
Cancer Research|August 1, 1980
Serum uridine levels in patients receiving N-(phosphonacetyl)-L-aspartateJ M Karle, L W Anderson, C Erlichman, et al.
Therapeutic Drug Monitoring|June 1, 1987
Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatographyR W Hardy, M J Moore, C Erlichman, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
American Journal of Hospital Pharmacy|February 1, 1986
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugsP G Tuffnell, M T Gannon, A Dong, et al.
Breast Cancer Research and Treatment|January 1, 1996
Male breast cancer: an 11 year review of 66 patientsS A McLachlan, C Erlichman, F F Liu, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancerC Erlichman, S J Soldin, J J Thiessen, et al.
Journal of the National Cancer Institute|February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injectionC Erlichman, R C Donehower, J L Speyer, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
The Hsp90 chaperone complex as a novel target for cancer therapyM P Goetz, D O Toft, M M Ames, et al.
Biochemical Pharmacology|June 29, 1995
Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicityJ Pressacco, B Mitrovski, D W Hedley, et al.
Cancer Research|August 1, 1980
Serum uridine levels in patients receiving N-(phosphonacetyl)-L-aspartateJ M Karle, L W Anderson, C Erlichman, et al.
Therapeutic Drug Monitoring|June 1, 1987
Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatographyR W Hardy, M J Moore, C Erlichman, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
American Journal of Hospital Pharmacy|February 1, 1986
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugsP G Tuffnell, M T Gannon, A Dong, et al.
Breast Cancer Research and Treatment|January 1, 1996
Male breast cancer: an 11 year review of 66 patientsS A McLachlan, C Erlichman, F F Liu, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancerC Erlichman, S J Soldin, J J Thiessen, et al.
Journal of the National Cancer Institute|February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injectionC Erlichman, R C Donehower, J L Speyer, et al.
Pageof 10